News Conference News ESC 2025 AMALFI: Modest AF Detection With ECG Patch Screening Michael O'Riordan September 05, 2025
News Conference News ESC 2025 High hs-CRP Linked to More CVD Events in Women Lacking Traditional Risk Factors Caitlin E. Cox August 29, 2025
News Conference News ESC 2024 New ESC Guidelines on BP and Hypertension Shift Treatment Targets Lower Yael L. Maxwell September 04, 2024
News Conference News ESC 2024 Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events Caitlin E. Cox August 31, 2024
News Conference News ESC 2022 INVICTUS: More Deaths, Stroke With Rivaroxaban in Rheumatic Heart Disease AF Michael O'Riordan August 28, 2022
News Conference News ESC 2022 Polypill Bests Usual Care in Patients With Recent MI: SECURE Michael O'Riordan August 26, 2022
News Conference News ESC 2021 Massive SSaSS Study Shows Switch to Salt Substitute Cuts Stroke, CVD Michael O'Riordan August 29, 2021
News Conference News ESC 2019 Nonphysician, Community Intervention Curbs CV Risk Factors: HOPE 4 Michael O'Riordan September 02, 2019
News Conference News ESC 2019 HiSTORIC Trial Supports Single-Test Rule-Out of MI Using High-Sensitivity Troponin Todd Neale September 01, 2019
News Conference News ESC 2017 VIVA: Could Population-Wide Screening Trial for AAA, PAD, and Hypertension Save Lives at Low Cost? Shelley Wood August 28, 2017
News Conference News ESC 2014 FAMOUS-NSTEMI: FFR Guidance Reduces Revascularization in NSTEMI Todd Neale September 01, 2014
News Conference News ESC 2013 ESC Congress 2013: Mix of Trials with Potential to Reshape Practice September 09, 2013
News Conference News ASCOT: Unexplained Long-Term Mortality Benefit Found with Atorvastatin August 29, 2011